Providers and researchers will learn more about state of the science in Research and Guidelines. Current research focusing on the genomics of this disease will be described and discussed.
Who Should Attend?
Health care providers, educators, researchers, clinical staff working in geriatrics, students, family members of patients with Alzheimer's Disease, and anyone else interested in learning about the relationship between Alzheimer's and genomics.
Objectives - After this presentation attendees will know/learn:
- Review and update the pathophysiology of Alzheimer’s Disease (AD)
- Describe the genetic mutations/changes (including epigenetics, mitochondrial DNA and telomeres) associated with early onset and late onset AD.
- Explain known AD therapies and clinical trials for the treatment of this disorder.
- Discuss the role of the International Genomics Alzheimer’s Project (IGAP) in research.
A new discounted rate is being offered for this webinar.
$10.00 for ISONG Members
$10.00 for ANA New York Members – use code ANANY2018 at registration
$15.00 for Non-Members